联系我们

论文查询结果	返回搜索

论文编号：	11631
作者编号：	2220160916
上传时间：	2020/6/15 15:23:20
中文题目：	S公司并购重组后整合与发展战略研究
英文题目：	Research on Integration and Development Strategy of S Company after Mergers and Acquisitions
指导老师：	郑轶松
中文关键字：	医药行业;并购重组;深度整合;发展战略;保障措施;
英文关键字：	Pharmaceutical industry; Mergers and Acquisitions; Deep integration; Development strategy; Safeguard measures
中文摘要：	近年来全球医药行业发展较为平稳，预计未来三年全球医药市场交易额将提升至1.4万亿美元，其增长率保持在3%--6%之间。基于全球医药行业良好发展趋势，国际医药巨头们普遍采取相关措施，强化核心竞争力，扩大市场占有份额，以增强自身综合实力，这也造成医药市场环境竞争加剧。在这种竞争愈演愈烈的医药行业市场环境下，为提升企业核心竞争力与综合实力，保障企业快速平稳发展，制定适应企业未来发展的战略规划至关重要。 本文以S公司为研究对象，以公司并购重组后的实际发展现状为研究背景，运用企业管理相关理论和方法，开展公司现状和所处环境分析；运用市场调研方法，客观阐述S公司的总体概况；运用PEST、SWOT分析方法，分析公司所处的宏观与微观环境，分析公司并购重组后发展中的相关问题；运用波特五力分析方法，结合S公司实际运营状况，分析公司所处医药行业市场的竞争态势，为后续进行公司深度整合与战略规划奠定基础。针对分析研究结果，明确S公司发展战略定位与目标；从企业管理架构、管理机制、企业文化及医药技术等方面，对并购重组后的S公司进行深度整合；制定S公司市场营销发展架构规划；同时针对性地规划公司未来发展战略。基于深度整合方案和发展战略规划，为保障其实施与开展，制定相关匹配保障措施。 本文研究致力于促进S公司并购重组后深度整合与融合，同时进一步根据公司实际状况与相关企业战略管理理论，规划S公司重组后的未来发展战略，力求为公司后续发展起到一定的指导作用。同时，也希望本文研究结果为相关企业进行企业并购重组与后续战略规划提供相关指导与借鉴。
英文摘要：	In recent years, the development of the global pharmaceutical industry has been relatively stable. It is expected that the global pharmaceutical market transaction volume will increase to 1.4 trillion US dollars in the next three years, and its growth rate will remain between 3% and 6%. Based on the good development trend of the global pharmaceutical industry, international pharmaceutical giants have generally taken relevant measures to strengthen their core competitiveness and expand their market share to enhance their overall strength, which has also caused increased competition in the pharmaceutical market environment. In this increasingly competitive pharmaceutical industry market environment, in order to enhance the company's core competitiveness and comprehensive strength, and to ensure the rapid and stable development of the enterprise, it is essential to formulate a strategic plan that adapts to the company's future development. This thesis takes S company as the research object, takes the actual development status of the company after merger and reorganization as the research background, uses the relevant theories and methods of enterprise management to carry out the analysis of the company's current situation and environment; uses market research methods to objectively explain the overall situation of S company ; Use PEST and SWOT analysis methods to analyze the company's macro and micro environments, and analyze related issues in the development of the company after mergers and acquisitions; use Porter's five-force analysis method, combined with the actual operation status of S company, to analyze the pharmaceutical industry market competition. This laid the foundation for the company's deep integration and strategic planning. Based on the analysis and research results, the company's development strategy positioning and objectives are clearly defined; from the aspects of enterprise management structure, management mechanism, corporate culture and pharmaceutical technology, deep integration of the S company after M & A and reorganization; formulation of the company's marketing development architecture plan; At the same time, plan the company's future development strategy in a targeted manner. Based on the deep integration plan and development strategy planning, in order to guarantee its implementation and development, formulate relevant matching safeguard measures. This thesis is devoted to promoting the deep integration and integration of S company after merger and reorganization. At the same time, it plans the future development strategy after reorganization of S company according to the company's actual situation and related enterprise strategic management theory, and strives to play a guiding role for the company's subsequent development. In addition, I also hope that the results of this thesis will provide relevant guidance and reference for related companies to carry out corporate mergers and acquisitions and subsequent strategic planning.
查看全文：	预览  下载(下载需要进行登录)